TherapeuticsMD Inc
TXMD
Company Profile
Business description
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.
Contact
951 Yamato Road
Suite 220
Boca RatonFL33431
USAT: +1 561 961-1900
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1
Stocks News & Analysis
stocks
Higher fair value for undervalued wide moat share
Investors are overly concerned with upcoming capital expenditures.
stocks
Fears of deteriorating loan quality sends bank share plummeting
We maintain our fair value estimate despite unfavourable economic conditions.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,026.90 | 46.30 | 0.52% |
| CAC 40 | 8,367.33 | 17.54 | -0.21% |
| DAX 40 | 24,626.89 | 44.33 | -0.18% |
| Dow JONES (US) | 52,111.21 | 235.10 | 0.45% |
| FTSE 100 | 10,484.22 | 23.80 | -0.23% |
| HKSE | 23,026.68 | 354.82 | 1.57% |
| NASDAQ | 25,640.49 | 342.88 | 1.36% |
| Nikkei 225 | 69,468.11 | 107.23 | 0.15% |
| NZX 50 Index | 13,545.56 | 50.32 | 0.37% |
| S&P 500 | 7,413.32 | 59.30 | 0.81% |
| S&P/ASX 200 | 8,823.40 | 46.50 | 0.53% |
| SSE Composite Index | 4,073.90 | 46.64 | 1.16% |